BRIEF-Teva Canada says Health Canada approved Cinqair
July 25 (Reuters) - Teva Pharmaceutical Industries Ltd
* Teva canada innovation announces approval of cinqair by health canada
* Treatment is expected to become commercially available to patients, by prescription, in late fall 2016
* Upon commercial availability of cinqair, teva canada innovation will launch teva support solutions in canada Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
© Thomson Reuters 2017 All rights reserved.